Evidence map›Paper›PMID 42374432›Full record

ArticleJournal of neuroinflammation2026

Hypoxic CA9-high mesenchymal-like glioma stem cells promote ANXA1-FPR1-dependent macrophage polarization in recurrent glioblastoma.

Hangqi Gao, Guiting You, Jianhuang Huang, Yijing Lin, Jiexin Huang, Risheng Liang, Caihou Lin

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hangqi Gao *Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Guiting You *Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Jianhuang Huang *Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Yijing LinDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Jiexin HuangDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Risheng LiangDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. doctorlr@126.com.
Caihou LinDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. grouplin@fjmu.edu.cn.

Funding

Fujian Provincial Department of Education Fund JAT220106Joint Funds for Innovation of Science and Technology, Fujian Province 2023Y9198Natural Science Foundation of Fujian Province 2025J01770Putian Science and Technology Program Project 2024S3f002
6 · The paper itself

Abstract

backgroundRecurrent glioblastoma (rGBM) is characterized by marked myeloid remodeling and a profoundly immunosuppressive microenvironment. Although carbonic anhydrase 9 (CA9) is a canonical hypoxia-inducible molecule linked to aggressive glioblastoma (GBM) behavior, its cell-state-specific distribution in rGBM and its role in glioma stem cell (GSC)-macrophage crosstalk remain incompletely understood.

methodsWe integrated public transcriptomic cohorts, single-cell RNA sequencing, quantitative proteomics, paired clinical specimens, and in vitro/in vivo functional assays to define the role of CA9 in rGBM. Malignant-cell states and tumor-associated macrophage (TAM) subpopulations were resolved at single-cell resolution, and intercellular communication was inferred computationally. CA9 gain- and loss-of-function models were established in GBM cell lines and patient-derived GSCs. ANXA1 expression and secretion were assessed by qRT-PCR, Western blotting, ELISA, and promoter-reporter assays. Macrophage polarization was evaluated using conditioned-medium transfer, recombinant ANXA1 rescue, and pharmacological FPR1 blockade with cyclosporin H.

resultsCA9 was upregulated in GBM, further enriched in mesenchymal and recurrent tumors, and associated with inferior survival. Single-cell analysis localized CA9 predominantly to a hypoxia-associated MES-like GSC subpopulation that expanded in recurrent samples and exhibited elevated stemness. Recurrent tumors also displayed increased SPP1 + immunosuppressive TAMs. Proteomic, transcriptomic, and cell-cell communication analyses prioritized ANXA1 as a CA9-associated downstream mediator with secreted immunomodulatory potential. Hypoxia induced both CA9 and ANXA1, and mutation of a hypoxia-response element attenuated ANXA1 promoter activation. CA9 depletion reduced ANXA1 expression and secretion, impaired GBM growth phenotypes, and attenuated hypoxia-driven ANXA1 induction. CellChat highlighted enhanced signaling between hypoxic MES-like GSCs and SPP1 + TAMs in recurrent GBM, nominating ANXA1-FPR1 as a leading ligand-receptor axis. Functionally, conditioned medium from CA9-high GBM cells promoted M2-like macrophage polarization, which was weakened by CA9 knockdown, partially restored by recombinant ANXA1, and markedly suppressed by FPR1 antagonism, supporting ANXA1 as a contributory paracrine mediator, and markedly suppressed by FPR1 antagonism. In vivo, CA9 depletion, and in CA9-intact tumors FPR1 blockade, reduced M2-like macrophage-associated signals.

conclusionsCA9 is enriched in hypoxic MES-like GSCs in rGBM and promotes an ANXA1-dependent paracrine program that supports immunosuppressive macrophage polarization. These findings identify a CA9-ANXA1-FPR1-associated neuroimmune crosstalk axis linking hypoxic stem-like tumor states to myeloid remodeling in recurrent GBM, with ANXA1 functioning as a contributory paracrine mediator rather than a sole effector of CA9-driven immunosuppression.

Indexed as

Annexin A1Antigens, NeoplasmBrain NeoplasmsCarbonic Anhydrase IXGlioblastomaMacrophagesNeoplastic Stem CellsReceptors, Formyl PeptideAnimalsCell Line, TumorHumansMesenchymal Stem CellsMiceNeoplasm Recurrence, LocalAnnexin A1Antigens, NeoplasmANXA1 protein, humanCA9 protein, humanCarbonic Anhydrase IXReceptors, Formyl Peptideannexin A1carbonic anhydrase 9FPR1glioma stem cellsneuroinflammationrecurrent glioblastomasingle-cell RNA sequencingtumor-associated macrophages

Identifiers

PMID42374432
PMCPMC13579895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.